C

CALLEGARO A. P.

Last name: CALLEGARO A. P.

2018 (v1)

Publication

Metadata-only

Impact of the M184V resistance mutation on virological efficacy and durability of lamivudine-based dual antiretroviral regimens as maintenance therapy in individuals with suppressed HIV-1 RNA: A cohort study

Gagliardini R. Ciccullo A. Borghetti A.

Background. Dual therapy (DT) with boosted protease inhibitors (bPIs) plus lamivudine has been shown to be superior to bPI monotherapy in virologically suppressed patients despite previous selection of the lamivudine resistance M184V mutation. We compared the virological efficacy of lamivudine-based DT in patients with and without a history of...

Uploaded on: April 14, 2023
2020 (v1)

Publication

Metadata-only

Evaluation of virological response and resistance profile in HIV-1 infected patients starting a first-line integrase inhibitor-based regimen in clinical settings

Armenia D. Bouba Y. Gagliardini R.

Background: Virological response and resistance profile were evaluated in drug-naïve patients starting their first-line integrase inhibitors (INIs)-based regimen in a clinical setting. Study design: Virological success (VS) and virological rebound (VR) after therapy start were assessed by survival analyses. Drug-resistance was evaluated at...

Uploaded on: April 14, 2023
2019 (v1)

Publication

Metadata-only

Prevalence of acquired resistance mutations in a large cohort of perinatally infected HIV-1 patients

Ungaro R. Taramasso L. Bruzzone B.

No description

Uploaded on: April 14, 2023